About Index Trending news
Lists
Pricing
Bain Capital Life Sciences

Bain Capital Life Sciences

Bain Capital Life Sciences

Latest investments Show all
$70,000,000
Venture capital (Series B)
Aptinyx Inc.
$103,000,000
Venture capital (Series A)
SpringWorks Therapeutics
Team Size
1–10
Employees
Past year's investments

Bain Capital Life Sciences participated in fewer than 3 rounds over the past year

Latest rounds
  • Aptinyx Inc.: Venture capital (Series B) ($70M)
  • SpringWorks Therapeutics: Venture capital (Series A) ($103M)
  • Dicerna Pharma: Post-IPO equity ($70M)